Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Nov. 11, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
On Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
On Nov. 17, 2023, Masimo announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter…
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
In 1991, the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was…
On Nov. 14, 1985, buckyballs were discovered by chemists Harold Kroto, Robert Curl, and Richard Smalley. While experimenting…